OMER(Omeros Corporation) · 财务报表

OMER(Omeros Corporation) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2016-12-31FY 截至 2017-12-31FY 截至 2018-12-31FY 截至 2019-12-31FY 截至 2020-12-31
营业收入$41.62M$64.83M$29.87M$111.81M$73.81M
毛利润$40.20M$63.75M$29.36M$110.94M$72.91M
营业利润−$54.28M−$43.90M−$112.22M−$146.04M−$156.92M
净利润−$66.75M−$53.48M−$126.76M−$84.49M−$138.06M
经营现金流−$51.50M−$36.23M−$103.74M−$60.07M−$100.09M
自由现金流−$51.63M−$36.58M−$104.30M−$60.41M−$100.37M
摊薄每股收益$-1.65$-1.17$-2.61$-1.71$-2.41

Omeros Corporation OMER